Background
Owing to the need to provide clear and practicable guidelines for infection control practitioners and others in operating theatres, the Hospital Infection Society (HIS) established a working party (WP) on infection control and operating theatres in 1999 to examine many of these issues. The remit of this group was:
(1) to review the scientific and other evidence for current infection control practices in theatre and following this, to make recommendations on which practices are essential, which are preferred and which are optional or are of little perceived benefit. (2) to produce rational, feasible and applicable guidelines for the environmental monitoring (including bacteriological air sampling) of operating theatre facilities, and specifically to address when monitoring is indicated, how it should be carried out and what action should follow if abnormal. (3) to consider optimal theatre facilities including when ultraclean or conventional theatre ventilation is required in the light of recent changes in surgical practice such as the increasing use of minimally invasive surgery. Work on this area is ongoing, and the conclusions reached will be available on the HIS website (www.his.org.uk) in the next 12 months or so.
The WP included microbiologists/infection control doctors, an infection control nurse, an operating theatre nurse, general surgeon, orthopaedic surgeon, aerobiologist, engineer and representatives of NHS Estates. The WP reviewed the literature in the relevant areas so that, as far as possible, the guidelines would be evidence-based. The WP also consulted with healthcare professionals and others as appropriate, and achieved consensus following discussion amongst the members on areas where scientific evidence was not available.
Draft documents were widely circulated to professional groups and organizations seeking comment and suggestions, and posted on the HIS website in early 2001. During the second half of 2001, the documents were revised in the light of this feedback, circulated to WP members and what follows is the result of this wide consultation exercise.
Introduction
Surgical operations and interventional procedures are performed in areas with various levels of microbiological control of the ventilation. The following areas are recognized:
(1) Conventionally ventilated operating suites (2) Ultraclean-ventilated (UCV) operating theatres (3) Unventilated theatres (4 
) Treatment rooms
There is no technical difference between an unventilated theatre and a treatment room. This section refers only to conventionally ventilated and ultraclean-ventilated theatres. Discussion as to which procedures should be performed in which facilities will form a separate WP report.
Limited advice exists on conventionally ventilated and UCV theatres in the UK Health Technical Memorandum (HTM) 2025. 1 The HTM gives limits on the microbiological (bacterial and fungal) content of air in empty and working theatres, but states in a margin note`precise guidance is inappropriate and will depend on local circumstances'. Whilst this remains true, it is apparent that many would welcome some advice on infection control aspects of these matters. This report seeks only to interpret HTM 2025 in a manner appropriate to infection control practitioners; we are not rewriting the standards within it.
HTM 2025 (volume AÐManagement Policy) gives the following role (paragraph 2.29)`Infection Control OfficerÐor consultant microbiologist, if not the same person, nominated by the management to advise on monitoring infection control policy and microbiological performance of the system. Major policy decisions should be made through an infection control committee. ' It also states (paragraph 2.14)`Increased health risks to patients will occur if the more specialised ventilation systems installed to supply high quality air to operating departments do not achieve and maintain the required standards. The link between postoperative infection and theatre air quality has been well established. Plants serving conventionally ventilated operating departments, for instance, will be required to ensure the separation of areas within the suite by maintaining a specific direction of airflow between rooms, even when doors are opened. They will also maintain the selected operating department environmental conditions regardless of changes in the outside air conditions or activities within the space. In addition ultraclean operating ventilation systems which are designed to provide an effectively particle-free zone around the patient while the operation is in progress, have been shown to reduce significantly postoperative infection in patients undergoing deep wound surgery. Their use for similar forms of surgery may well be indicated. ' One role of the infection control officer (ICO) in theatre commissioning and monitoring is to ensure the quality of the ventilation with respect to infection control issues. The ICO or infection control team (ICT) should be familiar with the outline structure, function and interrelationship of those engineering aspects that have an impact on infection control. A list of common problems in this respect and possible actions forms Annex A to this report.
Overall principles
The function of operating theatre ventilation is to prevent airborne microbial contaminants from entering surgical wounds. Under normal circumstances, the main source of airborne microbial contaminants is microscopic skin fragments given off by staff in theatre. A proportion of these skin fragments will be contaminated with microcolonies of bacteria resident, or perhaps transiently present, on that individual's skin. Whilst individuals will have different dispersion levels, overall dispersion is increased with movement and numbers of individuals present. 2 Other sources of airborne micro-organisms are usually less significant. These include improperly filtered outdoor air, contaminated fabrics worn by theatre staff and backtracking of contaminated air from outside the theatre. The patient is not usually a significant source of airborne contamination; their movement is usually minimal. However, there exists the potential that power tools can create an aerosol from the tissues and any micro-organisms within them.
Airborne micro-organisms can enter surgical wounds by one of two routes: they can either fall directly into wounds or they can land on exposed instruments, and possibly surgeons' hands, and can later be transferred into the wound. The significance of this latter route will vary with the area of exposed instruments and the duration of their exposure, but is thought usually to exceed the contribution of direct wound contamination. 3 
Commissioning
Commissioning must occur before an operating theatre is first used and after any substantial modifications that may affect airflow patterns in preexisting theatres (as part of a re-commissioning process). It is important that the ICT is involved at all stages from pre-design through to opening and that adequate time for commissioning is built in to the schedule, including an allowance of time for microbiological assessments. This may need particular consideration for facilities built under private finance initiatives. Contractual conditions should allow commissioning before handover of the theatre or have delayed acceptance after handover such that faults can be rectified.
Summary for conventionally ventilated theatres
Conventionally ventilated operating theatres must be commissioned before being used, after being built or modified substantially. Commissioning is a task for both the Estates Department and the ICT, and cooperation and co-ordination between them is important. Below is a summary of matters that should be addressed when commissioning conventionally ventilated theatres (and by whom) and the section covering it in this report:
± The theatre interior should be checked for obvious defects (ICT), Section 4.1.1. ± The air distribution within the theatre and between rooms in the theatre suite should be checked by smoke tracing (ICT), Section 4. 
Theatre interior
Inspection of the theatre interior before it is handed over from the building contractors to the hospital is the last convenient occasion to rectify faults. The following observations should be made:
± pressure-release dampers should move freely and be partially or fully open when doors are closed and move to shut when doors are opened; ± doors must close properly; ± the flooring should have no cracks or gaps in it and its coving joins to the wall; ± painted surfaces and finishes should be smooth, complete and without cracks; ± that there are minimal fixtures, shelves etc.; ± the windows should be sealed; ± the ceiling should be solid.
Ventilation engineering
The risk from airborne micro-organisms is minimized in the ventilation of conventionally ventilated theatres in three ways:
(1) by filtration of supplied air; (2) by dilution of contaminated air in the theatre; and (3) by preventing entry of contaminated air from areas outside the theatre.
The ICO/T should carry out airflow visualization (smoke testing) to ensure turbulent airflow in the theatre, particularly around the position of the operating table (a puff of smoke should disperse within seconds of creation). It should also be established that supplied air does not`short-circuit', i.e., take a direct route out of the theatre such that it cannot entrain contamination generated in the theatre. Sources of such`airflow indicators' are in Annex B. Large volume smoke generators are useful for tracing larger airflow patterns (also in Annex B). Fire alarms systems in the theatres should be disabled during testing.
Airflow visualization should also be used to establish that air flows in the desired direction between rooms in the suite (with all doors closed):
± from the theatre into the anaesthetic room, the disposal room, the corridor; ± from the anaesthetic room and scrub area into the corridor; ± air should either flow from the preparation room into the theatre if it is used for lay-up or they should be at equal pressure if used as a sterile pack store (i.e., no direction of flow between them). Air should flow into the corridor from a preparation room used either for lay-up or as a sterile pack store. The ICO should request a signed document from a senior member of the Estates Department that the ventilation to the theatre suite, including the airhandling unit, has been inspected and that the theatre is satisfactorily constructed, finished and is functioning to specifications. A sample letter forms Annex D to this report. Guidance on completion of this letter forms Annex E.
Setback status
As an economy measure, ventilation rates can bè set back' when the theatre is not in use. Ventilation should not be turned off completely, but volumes can be reduced provided that pressure relativities are maintained between the different areas of the operating suite to prevent backflow of contamination into clean areas. If a setback system is in place, there must be a clear visual indication in the theatre of whether the ventilation is on setback or normal flow rates. If pressure relativities are maintained during setback, all air in the theatre will have passed through the filters in the air-handling unit and there will be little microbial dispersion in an unused theatre; therefore we consider that the theatre will be usable 15 min after full ventilation has been restored. Control of setback is normally on a timed basis and there should be an override linked to the operating light or a movement detector so that setback does not occur when lists over-run. There must be a setback override to allow for unforeseen use of the theatre to occur.
Air change rates
Details of ventilation rates to the theatre should be obtained from the Estates Officer and used to calculate air change rates (see Annex D). An air change is defined as occurring when a volume of air equivalent to the volume of the room has been supplied to or removed from that room (whichever airflow is greater). The rate of air change is usually given in terms of air changes per hour (ACH) and is derived from the volume of a room and the ventilation rate. Design and commissioning engineers do not however express ventilation parameters in terms of air change rates; they will express ventilation rates in terms of volume of air supplied or extracted per unit time, usually as cubic metres of air per second. The air change rate in preparation rooms used for laying-up sterile instruments should be around 37 ACH; a greater air change rate than in theatres (the main route of airborne contamination entering surgical wounds is probably via instruments 3 ). If preparation rooms are used only as sterile pack stores, the ventilation rate should be around 11 ACH.
If either the operating theatre or preparation room have been built to dimensions different from those in HBN 26, 5 ventilation rates given in HTM 2025 should be adjusted to achieve the required rate of air changes. Effective air changes will only occur if airflow is turbulent and there is no short-circuiting. These should have been established by smoke testing (see 4.1.2).
Pressure differentials and airflow
The direction of airflow between rooms in a theatre suite is used to ensure that there is no backflow of air from either`dirty' rooms in the suite or from contaminated areas in the hospital. Air flowing between rooms can be measured in terms of the pressure differential between those areas. The pressure differential results from the volume of air flowing between those areas per unit of time and the size of the gap though which it flows. It is usually measured in units of pascals or sometimes in terms of inches or millimetres of water. Pressure differentials between rooms in the theatre suite are given in HTM 2025, volume B (Design considerations). The desired pressure differentials are small and not easily measured (usually either by an electronic micromanometer or inclined fluid manometer). The desired pressure differentials between the different rooms will vary from around 9 to 30 Pa (1 Pa is equivalent to the pressure exerted by 0.004 or 0.1 mm of water, i.e., a very small amount of pressure).
We advise that the ICO request a signed document from a senior member of the Estates Department that the pressure differentials have been assessed by the commissioning engineer and are satisfactory (see Annex D). However as the value of the differentials are as much a reflection of the size of the gaps that the air flows through, as well as the volume of air flowing through those gaps and the robustness of flow is related more to the volume flowing through a gap than the pressure across that gap, we do not consider the actual values of pressure differential to be vital in terms of infection control. The ICO/T should have carried out airflow visualization with smoke tubes to observe robust directional flow at the same time as determination of turbulent airflow in theatre (see 4.1.2).
Microbiological sampling
HTM 2025, 1 volume C (validation and verification) states (paragraph 5.33).`The level of airborne bacteria introduced by the supply air can be checked by closing all doors and leaving the operating room empty with the ventilation system running for one hour, after which a bacterial sampler mounted on the operating table should be activated remotely. Aerobic cultures on non-selective medium should not exceed 35 bacterial and/or fungal particles per cubic metre of ventilating air'.
When to sample The most appropriate time for microbiological commissioning of an operating theatre should be shortly before it comes into use. The theatre should have had an`in-depth' clean and be thoroughly clean and dust-free. The air handling unit should have been operating at normal flow rates (i.e., not on setback ventilation) continuously for at least 24 h before sampling. Given the usual timeframe for sampling, it is usually only the production of satisfactory microbiological sampling that is required to enable a new or refurbished theatre to come into use. It is therefore vital that:
(a) the checks on the engineering aspects listed above should have already occurred and be satisfactory before microbiological sampling is done; (b) false-positive microbiological results (primarily from airborne contamination dispersed by the person doing the test) do not cast doubt on the adequacy of the ventilation.
The protocol given in the HTM is skeletal and one purpose of these guidelines is to record the practical experience of those who have been involved in this field.
How to sample In a clean, well-ventilated operating theatre, the main source of airborne contamination will probably be contaminated skin particles dispersed from people, even when wearing theatre clothing. It is vital that any microbial air sampler is only operated once all people are out of both the operating room and any area that feeds air into the operating room (such as the preparation room). Also, before the sampler operates, sufficient time must be allowed for the ventilation to dilute and disperse the contamination generated during the setting-up of the sampler. It is not good enough to switch the sampler on and then stand away from it. This will be one of the considerations affecting the choice of a suitable sampler. Some samplers can be operated remotely via a cable from outside the theatre, by an infra-red remote control or by a time-delay mechanism on the sampler. HTM 2025 advises that the theatre be empty for 1 h before sampling. This can make commissioning a suite with more than one operating theatre timeconsuming. Each change of air will, given perfect mixing, produce a 63% reduction in pre-existing air and its entrained contamination. If there are, for example, 20 air changes per hour in a operating theatre (one air change every 3 min), in 1 h airborne contamination levels will be reduced to 0.0000002% of their former levels by dilution alone (there will be additional losses due to particles settling-out over this time). It does not seem unrealistic to leave the operating theatre unoccupied for 15 min before sampling, in which time airborne contamination should have been reduced to less than 1% (actually 0.67%) of its former levels, if the ventilation is working adequately. If the ventilation is defective, either in the rate of airflow or its distribution (such as shortcircuiting out of the theatre without diluting preexisting air), it may be more evident if left for 15 min rather than 1 h (the contamination dispersed by the person setting the sampler up will not have been diluted out or have had a chance to settle-out). A gap of 15 min between set-up and sampling will also allow time for generation of a duplicate sample, useful for confirming unexpected results.
Clothes worn when doing microbiological testing in theatre are unimportant. Local dress codes should be observed but normal theatre wear does little to reduce dispersion; besides which remote operation of the sampler and the time gap between leaving the theatre and taking the sample make such dispersion unimportant.
How much to sample The volume of air to be sampled is not specified in the HTM. It is left to the individual directing the sampling and will be determined by the microbial numbers being sought and the sampling equipment. We suggest that sampling volumes around 1 m 3 (1000 L) are optimal. Using volumes above this generates no substantial problems until either the colonies on the incubated plate get too crowded to enumerate accurately or the agar starts to dry out due to the volume of air passed over it. Using volumes lower than this may result in interpretational difficulties and tends to make the data more qualitative as the volume decreases. It also gives undue weight to plate contaminants. We cannot be prescriptive on this matter, but advise sampling volumes greater than 0.25 m 3 (250 L) and optimally around 1 m 3 (1000 L). Whatever air volume is chosen, the sampler used should be capable of sampling it without causing excessive drying of the recipient agar surface.
It is important to ensure that the sampler is clean before use. It should also be run briefly in the theatre before the agar is loaded to blow any contamination out of the sampler. We recommend taking at least two samples per theatre, as this lessens the possibility of technical errors interfering with successful commissioning of a theatre. A short summary of the attributes of the common samplers available is given in Annex C. The choice of growth medium and recovery conditions can be varied according to the nature of the exploration and perceived problems. Nutrient agar incubated for two days at 37 C is an acceptable method for general work. If there is a more specific investigation, appropriate media and culture conditions can be used. The larger the plate used, the greater volume of air it can sample before drying-out of the agar interferes with bacterial recovery (e.g., large volume slit samplers, which can sample several cubic metres of air, use 15 cm plates). The plates should be poured such that the surface is flat (no lumps, no slope).
If the quality of the agar plates is at all suspect, pre-incubation (under conditions that match the incubation of the samples to be taken) will allow those plates with contaminants to be discarded.
UCV theatres
UCV theatres must be commissioned before being used, after being built or modified substantially. Commissioning is a task for both the Estates Department and the ICT, and co-operation and co-ordination between them is important. The following is a list of matters relevant to infection control that should be addressed (and by whom) and the section of this report in which they are covered: ± The theatre interior should be checked for obvious defects (ICT), Sections 4. 
Theatre interior
See section 4.1.1 for general theatre interior requirements. In addition, the operating lights should ideally be of a type that offers minimal interruption to the airflow pattern, but in reality such a choice may well be a compromise between illumination efficacy and airflow considerations.
Ventilation engineering
Control of postoperative infection caused by airborne micro-organisms is achieved in UCV theatres by exclusion of contamination from the wound. Filtered air descends in a uni-directional flow over the patient, creating a`clean zone', rapidly removing contamination generated within that zone and preventing entry of contaminated air. The large volumes of air required to maintain this zone make it necessary to recirculate air from within the theatre. Filtration of this recirculated air is essential to prevent contaminated particles also being recirculated. The filters used are HEPA filters (see Annex H). The existence of this clean zone largely negates the need for control over air movement between rooms in the theatre suite. However, there is still a need for the preparation room to be at positive pressure relative to other areas, and to have a high airchange rate if used for laying-up instruments.
Air change rates and velocity
UCV theatres need to be tested to ensure:
(1) that the velocity of air within the clean zone is sufficient to result in a robust, unidirectional flow capable of resisting ingress of contaminated air from outside the zone (Section 4.2.3.1); (2) that filters are intact and properly seated so as to remove microbial contamination from both incoming and recirculated air (Section 4.2.3.2).
Air velocity and flow characteristics
A grid is marked out in the clean zone (at least 2.8 metres square) such that the area is delineated into 100 squares (10 by 10), each about 280 to 300 mm 2 (see Figure 2 ). In each of these squares, air velocity measurements are taken at 2 m above floor level. The air velocity should average 0.38 m/s if there are partial walls around the clean zone ending at a height of around 2 m above floor level (the usual case), or 0.3 m/s if there are full walls to 1 m or less above floor level. In the central 36 (6 by 6) squares, the velocity is also measured 1 m above floor level and should be at least 0.2 m/s. These data should be generated by the commissioning engineer and passed to the local Estates Department.
Airflow visualization of the resistance of the unidirectional flow to ingress from outside provides useful reassurance of the robustness of the system. Smoke should be aimed at the unidirectional flow from outside the area with various objects that may interfere with the airflow, principally the operating theatre light, in a variety of realistic positions and lack of ingress observed.
Contamination removal
To assess that the tested filters are intact and properly seated so as to remove microbial contamination from both incoming and recirculated air is tested by either microbiological air sampling or exclusion of tracer particles generated outside the clean zone. Volume C of HTM 2025 (1994) (Validation and verification), paragraph 5.36a states`air leaving the final diffuser or final filters should contain not more than 0.5 CFU/m 3 of air. If the air filters have been tested after installation by a particle penetration test, this test is not necessary.' We consider particle testing to be a better test of filter integrity than bacteriological sampling: it poses a greater challenge to the filter assembly (there will be a far greater number of tracer than microbiological particles) and is less prone to technical errors (sampling for very low numbers of airborne bacteria is a skilled exercise). In addition to this test, there is a test to assess the capacity of the airflow in the clean zone to resist penetration from outside. Details of this test can be found in the same volume, paragraphs 5.28±5.31. In essence, after the filter installation has been shown to prevent passage of particles (i.e., the filters are not holed or mis-seated), DOP (dispersed oil particles) or other appropriate particles are generated outside the clean zone and their ability to enter into the clean zone assessed. This test would be done by expert consultants acting for the Estates Department or the commissioning engineers and the ICO should be informed of the result.
As the uni-directional flow in the clean zone will resist contamination from outside, there is no necessity to have the air movement control schemes (i.e., air moves from the cleanest to progressively less clean areas) that should exist in conventionally ventilated theatres. However there is still the problem of instruments being contaminated with airborne micro-organisms transferring that contamination into the wound. 3 Thus if instruments are laid up in a preparation room, that room should have air, filtered to the same specification as for the operating theatre, supplied such that it is at a positive pressure to surrounding areas. The air change rate in preparation rooms used for laying-up sterile instruments should be around 37 ACH. It is important to prevent contamination of instruments exposed in the theatre, whether they have been laid up in a preparation room or in the theatre itself. Ideally, exposed instruments should be kept within the clean airflow, just as the wound is. However, the minimum size of the clean zone is 2.8 m Â 2.8 m. It is, in practice, usually impossible to site all laid-up instruments within this area. Other than the diluting effect of ventilation on airborne contamination outside the clean zone, control of such contamination on exposed instruments can only be by limiting the duration of their exposure. This will require good co-operation between the team in only laying-up those instruments that can be accommodated within the clean zone yet providing all instruments as soon as they are required. If the clean area could be sufficiently large to accommodate laid-up instruments, there would be a higher quality assurance of contamination prevention. This matter should be considered at the design stage.
Microbiological sampling
When commissioning an ultraclean theatre by microbiological sampling, HTM 2025 (1994) volume C chapter 5, Figure 1 shows 13 sampling points reproduced in Figure 2 of this document:
(1) one at each corner of the unidirectional airflow zone perimeter, (2) halfway along each side of the perimeter, (3) one at each corner of the inner zone, (4) one in the centre.
Volume C of HTM 2025 (1994) (Validation and verification), paragraph 5.36a states`air leaving the final diffuser or final filters should contain not more than 0.5 CFU/m 3 of air. If the air filters have been tested after installation by a particle penetration test, this test is not necessary.' However, it is not uncommon, if the theatre has already been tested by particle generation, for single or duplicate microbiological samples to be taken at the centre of the clean zone. The air should contain less than 0.5 CFU/m 3 , or one colony for every 2 m 3 sampled (HTM 2025, volume C paragraph 5.36a).
Accurate sampling for such low levels of bacterial contamination involves stringent technical requirements and operator skill. There is no need for the person operating the sampler to be outside the theatre when the sample is taken, as the unidirectional airflow should exclude ingress of contamination from outside that zone, but the sampler should still be operated remotely from outside the unidirectional flow canopy (someone bending over the sampler to switch it on and off would greatly compromise air quality). The sampler must be absolutely clean and should be run for a while in the clean air to remove any contamination from it before the plate is inserted. The ventilation should have been operating at full supply rate for at least 5 min before sampling occurs. So that airflow patterns are not unduly disturbed by the act of sampling, the pump for the sampler should be either outside or close to the edge of the clean zone and its discharge, if directional, should be directed out of the clean zone. The larger the volume of air sampled, the greater the assurance of an accurate result; to detect 0.5 CFU/m 3 , the volume sampled must be at least 2 m 3 , preferably more, so high volume samplers are essential. Using 15 cm wide Petri dishes, the agar will dry out to levels that discourage bacterial growth after more than about 10 m 3 has been passed over its surface. As low numbers of plate contaminants can significantly affect results of commissioning UCV theatres, poured agar should be pre-incubated before use (under conditions that match the incubation of the samples to be taken) to exclude plate contaminants. Incubation, as with conventionally ventilated theatres, should normally be at 37 C for two days.
Monitoring

Conventionally ventilated theatres
Routine monitoring
Provided that engineering parameters are satisfactory and regularly monitored, microbiological air sampling in conventionally ventilated theatres need not be done on a routine basis, unless by local agreement. Microbiological air sampling of empty, conventionally ventilated theatres should be done either as part of an investigation into theatreacquired infection with a possible airborne element or after any changes that may affect airflow supply rates or distribution patterns. This would include alterations to the fabric of the theatre or changes to the ductwork distribution that may affect airflow to or within a theatre suite, but would not include routine filter changes. Such sampling should be identical to that on initial commissioning of the theatres.
Sampling in a working theatre
Microbiological sampling during normal working can be done as part of the microbiological commissioning process. HTM 2025, 1 volume C (Validation and verification) states (paragraph 5.35):`A check of airborne bacteria should be carried out as soon as possible after handover. Unless there are unusually high numbers of personnel or extensive activity in the room, the number of airborne bacteria and/or fungal CFUs averaged over a five minute period, should not exceed 180 per cubic metre. This work should be carried out by the nominated infection control officer or consultant microbiologist if not the same person.' This standard has subjective elements to it: the existence of excessive numbers of personnel in the room and an assessment of their activity levels. The need to average the sample over a 5 min period means, in effect, taking a continuous sample over that time or a sequential series of continuous samples.
The positioning of the sampler in relation to the incoming flow of clean air or the dispersing sources (theatre staff) will also have an effect on the microbial numbers recovered. Sampling in a working theatre is very much a secondary check on engineering parameters. If, for example, airborne counts in excess of 180 CFU/m 3 were to be found, remedies other than engineering-based are not readily applicable (these would be to reduce the number of staff in theatre, their activity levels or their individual dispersion levels). The only practicable course of action is reassessment of the ventilation parameters. This would comprise rechecking the commissioning engineer's airflow data with the local Estates Department; re-assessing air distribution patterns to ensure effective dilution and possibly re-balancing or redirecting ventilation output to achieve more effective contamination dilution.
Sampling in a working theatre is as much a check on how that theatre is being used as on the engineering parameters. We do not consider that it should be done as a routine exercise. Such sampling should be employed selectively where use of a theatre may have an effect on surgical wound infection.
The air handling unit
Annex 1 of HTM 2025, volume D (Operational Management) requires that the humidifier and cooling coil in air handling units be disinfected at least six-monthly. It also states`if any suspicion arises as to the possible contamination of the system then the microbiologist should be requested to take swab tests from all drain trays and cooler battery/ cooling coil tubes and fins'. We consider it inappropriate to carry out such microbiological investigations on cooling coils as they do not contribute significantly to the microbial quality of air delivered by the system. We also consider it inappropriate to carry out such investigations on humidifiers since they should generate humidity via steam, in which case they pose a negligible risk. Humidifiers that aerosolize recirculated water (spinning disk humidifiers) pose too high a hazard to require routine microbiological assessment: they should not be used.
Annex 1 of volume C (Validation and verification) makes similar recommendations for ventilation plant about to come into service. Again we consider that physical cleaning, rather than disinfection with microbiological monitoring, is more appropriate.
If there is a build-up of biofilm on a cooling coil, the five parts per million chlorine recommended for disinfection is unlikely to make any contribution to its removal, even on a temporary basis. Use of a steam cleaner, given as an alternative to chlorine, may be more appropriate but any effective method of physical removal of biofilm is acceptable.
UCV theatres
Routine monitoring
The pattern of airflow in a UCV theatre should be stable given reasonably constant air velocities. HTM 2025 volume D (Operational Management, para 5.8 and 5.9) recommends that air velocity assessment and bacteriological air sampling in a working theatre are done annually. As has already been noted, sampling in a working UCV theatre is a difficult exercise and we consider that, given no change in the ventilation, equipment or use of the theatre, such sampling is unlikely to give fresh data and is thus difficult to justify.
We recommend that UCV theatres are re-commissioned annually and on HEPA-filter replacement or disturbance. We recommend that, in empty UCV theatres, such testing is best accomplished by using inert particles rather than by bacteriological testing. Sampling in a working UCV theatre, as with conventional ventilated theatres, need not be done routinely but can form part of specific investigations.
Sampling in a working UCV theatre
Microbiological sampling during normal working can be done as part of the microbiological commissioning process. HTM 2025, (b) air sampled close to the wound site during operations, that is within 300 mm of the wound should on average, contain less than 10 CFUs/ m 3 of air using conventional cotton clothes. Levels less than 1 CFU/m 3 can be expected when using occlusive clothing or body exhaust systems; (c) air sampled at the perimeter of the clean zone during surgery should contain not more than 20 CFUs/m 3 using conventional clothing and levels less than 10 CFUs/m 3 when using occlusive clothing or body exhaust systems.
However, as with sampling in working conventionally ventilated theatres (5.1.2), such a course of action is more an indirect assessment of operating theatre procedures, personnel and practices than of engineering parameters. Given adequate airflow and engineering controls, it is factors such as individual dispersal, behaviour and clothing that will affect the airborne bacterial count. It is unrealistic to expect that if it is satisfactory on one occasion, it will consistently be satisfactory (and vice versa). Such sampling provides only a`snapshot' of the effects of other parameters that could be better observed and addressed as matters of theatre practice. As such, these matters are best observed directly and dealt with as matters of theatre procedure and discipline; there should be no need repeatedly to prove their need by the results of bacterial sampling. In addition, sampling air within 300 mm of the wound during ultraclean surgery, is a highly exacting exercise where minor technical errors may lead to false-positive or -negative results. We therefore do not recommend air sampling in ultraclean ventilated operating theatres during surgery as a commissioning exercise.Ifperformed bytechnicallyskilledoperators, it has a role in specifically directed investigations but this is not interchangeable with routine, undirected sampling. 
Additional references/documents: references and documents used in the model letters and certification for conventionally and UCV theatres (annexes D±H)
Annex A: Problems and actions
A risk assessment should be carried out involving an assessment of the abnormal bacteriological results, the likely cause and the ease of rectifying this, the type of theatre and the procedures carried out there, and the consequences of theatre closure. Check that sampling technique is satisfactory, then repeat sampling. If it still fails, discuss possibilities with people experienced in theatre testing. Explore possible engineering causes of failure (see Table II ). Infection control team to discuss implications and options.
UCV theatre fails bacteriological testing (empty theatre) Check that sampling technique is satisfactory (check with someone experienced in such sampling), then repeat sampling. If still fails, test particle penetration of filters outside clean zone to inside zone; test air velocity within clean zone.
Conventionally ventilated theatre fails bacteriological sampling (working theatre)
Test theatre empty, check airflow rates and distribution. If satisfactory, assess staff numbers inside theatre, activity levels and test again.
UCV theatre fails bacteriological testing (working theatre)
Test theatre empty as above; check that sampling technique is satisfactory. Repeat sampling. If still fails, discuss possibilities with people experienced in theatre testing.
Clusters of infection known or suspected (having excluded more obvious causes such as changes in operative procedures)
If an airborne component is suspected or needs to be excluded, do a full check on the ventilation: filters in air-handling unit, ventilation rates, airflows in theatre (and prep room), airflows between rooms, bacteriological air sampling in empty theatre, ascertain if anything has changed since before the cluster occurred.
Theatre staff`uncomfortable' This is primarily a problem for the Estates Department, but if staff are uncomfortable because of draughts (i) ensure that ventilation rates are not altered and (ii) if airflows are redirected by adjusting fins on outlets, smoke test to ensure air is still sufficiently turbulent at the table to disperse contamination. Until the 1980s the only microbial air samplers commercially available for measuring the microbial concentration of the air in operating theatres were the slit sampler and the sieve impactor. All the microbial aerosol levels recommended in guidance and in the papers of Whyte, Lidwell and others are based on experiments carried out with the large volume (700 L/min) slit samplers. New types of microbial air samplers have appeared since then. However, sampling air in operating theatres does not form a substantial section of this market, so many are not suitable.
The following points need to be considered in selection:
(1) Can it sample a suitable volume of air (greater than 2 m 3 may be needed in UCV theatres) within a reasonable length of time (e.g., 10 min) or before dehydration effects may occur? (2) Can it be operated remotely (e.g., infra-red control or via extension lead)? (3) Is it easy to use and clean? (4) If unusual plates, strips or filters are used, how much do they cost? (Some can cost up to £5 per unit Letter should be on management's headed paper.
Microbiologists should check that the recipient of the letter is the person who is the Designated Person (an individual who has overall responsibility for the operating theatre systems within the premises and who has a duty under the Health and Safety at Work Act 1974, to prepare and issue a general policy statement on health and safety at work, including the organization of and arrangements for, carrying out that policy.)
Certification of compliance for operating theatres.
Please confirm that the following have been tested and certified as to be correct to the design brief and the relevant standards and guidance by signing and returning to me the attached certificate (Certificate of Compliance) (All areas not shaded should be filled-in) Note: Site storage shall be permanently clean, dry and dust-free.
Outstanding defects
The outstanding defects listed should be those that relate to hygiene, air change rate and airflow pattern.
10 Comments related to possible microbiological problems
The comments should be concerns relating to possible microbiological contamination. The HEPA filter should comply with BSEN1822 and be site tested to BSEN1822 parts 4 and 5.
The penetration resistance of the UCV clean zone is set out in HTM 2025 Validation and verification, paragraphs 5.30 and 5.31.
The grade of HEPA filter depends on the specification of the manufacturer of equipment.
2 Monitoring system to show clean and dirty state of HEPA filter.
Describe monitoring method and indicate pressure readings on filters when clean and when dirty.
3 Type of system fitted.
Indicate manufacturer and type of system. Horizontal or cross-flow systems are not recommended by HTM2025.
4 Test procedure for verification of system parameters.
Test method should follow HTM2025, volume C (Validation and verification), paragraph 5.0: The following test applies to a typical UVC system. Any unit which does not comply with this standard design should have its method of verification agreed and documented. Data should include discharge area, diffuser height (from 2.45 to 2.9 m from finished floor level subject to local conditions and operating lamp selection) and whether full or partial walls are fitted.
Comments:
5 Vertical discharge ultraclean unit.
Test results inline with HTM2025.
The test results should comply with HTM2025 validation and verification Chapter 5 (Performance tests) and the results tabulated as detailed in tables above.
6 Comments related to possible microbiological problems
Comments regarding any problems that could compromise microbiological standards. 
